Skip to Content

Tag: Needham


News

Survey finds improving supply for CPAP devices 

March 18, 2024HME News Staff

NEW YORK – Respondents saw a 6% increase in sleep patient volume, on average, in the last 12 months, according to the HME Sleep and Oxygen Survey for the first quarter of 2024 from Needham and Co.  Respondents expect 6.5% growth in the next 12 months.  “We suspect that the increase is due to improving flow generator supply and HMEs engaging both new and backlogged patients that resulted from the Philips Respironics recall,” the report stated.  Other...

CPAP Device, Needham, Patient volume, Sleep Therapy


Read Full Articlered right arrow icon

News

Survey: Sleep volume growth anticipated

May 3, 2023HME News Staff

NEW YORK – Providers expect to see double-digit growth in their sleep patient volume over the next 12 months as flow-generator availability improves, according to the first quarter 2023 HME Sleep and Oxygen Survey from Needham.  Respondents reported that they have been able to purchase their desired flow generators within required timeframes as follows: Philips, 15.6% (up from 12.1% in Q3 2022); Fisher & Paykel, 25% (up from 9.4% in Q3 2022); and ResMed, 61.4% (up from 39.2% in Q3 2022).  The...

Needham, Philips, ResMed, sleep growth


Read Full Articlered right arrow icon

News

Report: Providers anticipate sleep rebound

September 28, 2022HME News Staff

NEW YORK – HME providers saw a 6.3% decline in their sleep patient volume in the last 12 months, but they expect double-digit growth in the next 12 months, according to the third quarter HME Sleep and Oxygen Survey from Needham.  The decline in sleep is mainly due to a shortage in flow generators. The eventual re-entry of Philips into the flow generator market appears likely to come mostly at the expense of smaller competitors rather than ResMed, according to the survey.  Respondents...

CPAP Recall, Home Oxygen, Home sleep, Needham


Read Full Articlered right arrow icon

News

Report: Recall causes shifts in sleep therapy market

April 5, 2022HME News Staff

NEW YORK – HME providers expect to shift an average of 58.4% of their Philips Respironics flow generator purchases and an average of 30.2% of their mask purchases to other companies due to the recall, according to the first quarter HME Sleep and Oxygen Survey from Needham.  That’s up from the 56% and 23.1%, respectively, reported in the third quarter survey.  “ResMed should gain market share over the (next 12 months),” the survey states. “Respondents...

CPAP Recall, Needham, Philips Respironics, ResMed


Read Full Articlered right arrow icon

News

Recall will shift buying preferences, survey finds

August 10, 2021HME News Staff

NEW YORK – Providers expect to permanently shift an average of 56% of their Philips flow generator purchases and an average of 23.1% of their Philips mask purchases to other companies due to the recall, according to Needham’s 3Q21 HME Sleep and Oxygen Survey.  “And ResMed looks likely to be a beneficiary of this share movement,” Needham states. “Over the near-term, respondents expect ResMed’s share of their flow generator purchases to increase by 3.7% and...

Needham, Philips Recall


Read Full Articlered right arrow icon

News

Pandemic impacts patient volume, survey says

June 3, 2020HME News Staff

NEW YORK - Respondents report, on average, a 4.1% decline in their sleep resupply business due to the COVID-19 pandemic in the “2Q20 HME Oxygen, Sleep and Complex Rehab Survey by Needham and HME News.”Respondents saw their sleep patient volume increase by 5.5% in the last 12 months before the pandemic and expect their volume to grow by 5% over the next 12 months.“Both of these growth rates are lower than our prior survey results of 15% and 15.3%, respectively,” writes analyst...

Complex Rehab, Needham, Patient volume, Respiratory, Survey


Read Full Articlered right arrow icon

News

Survey predicts nice bump in POC adoption

January 29, 2020HME News Staff

NEW YORK - Portable oxygen concentrators are expected to increase from 23.9% of the ambulatory oxygen market to 28.2% over the next 12 months, according to the results of a new survey from Needham.Respondents expect 11.3% growth in their POC unit purchases over the next 12 months, with Applied Home Healthcare's OxyGo and Inogen's G4 the two highest rated devices, according to the 4Q19 HME Oxygen, Sleep and Complex Rehab Survey of 48 companies.“Inogen looks likely to gain market share,”...

Needham, Survey


Read Full Articlered right arrow icon

News

Survey: Providers aren't jumping to buy POCs

June 28, 2019HME News Staff

NEW YORK - Providers expect only 2.6% growth in their POC purchases over the next 12 months, according to a new survey from Needham & Company. This, despite also expecting POCs to increase from 21.5% of the ambulatory oxygen market to 31.5% over the next 12 months, according to the 2Q19 HME Oxygen, Sleep and Complex Rehab Survey. Additionally, providers report Applied Home Healthcare's OxyGo as the highest rated POC at 5.1 out of 7, followed by Applied's OxyGo Fit. On the sleep side,...

CPAP, Needham, Portable Oxygen Concentrator (POC)


Read Full Articlered right arrow icon

News

Providers hold off on ordering—for now

December 20, 2018HME News Staff

NEW YORK - The majority of HME providers are reducing or delaying orders for oxygen and CPAP equipment, but that is likely to be temporary, according to a new survey for the fourth quarter of 2018 from Needham & Company. Sixty three percent of respondents said they would reduce or delay orders for oxygen equipment in response to an any willing provider provision set to go into effect Jan. 1 for Medicare, according to the survey of 150 providers. Respondents said they would also reduce or delay...

CPAP, Home Oxygen, Needham


Read Full Articlered right arrow icon

Also Noted

Growth in the sleep market continues

September 12, 2018HME News Staff

BOSTON - Sleep center patient volume grew 7% in the last 12 months and is expected to grow 9% in the next 12 months, according to the results of a new survey conducted by Needham & Co. ResMed looks likely to lose 2% of flow generator prescription share, but gain branded mask prescription share. For flow generators, Respironics' share is up 1.1%, Fisher & Paykel's share is flat and other companies' share is up .8%. ResMed's mask ratings are slightly above its competitors in all three...

Needham, ResMed, sleep patients


Read Full Articlered right arrow icon